Alps Group Inc

Alps Group Inc (NASDAQ:ALPS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors ALPS SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

• Alps Group Subsidiary MyGenome Achieves Key Whole Genome Sequencing Accreditation (2026-06-09)
• Alps Group Subsidiary MyGenome Achieves Key Whole Genome Sequencing Accreditation, Expanding Market Access (2026-06-09)
• Alps Group receives Nasdaq delisting warning for sub-$1.00 bid price (2026-05-19)
• Alps Group Appoints Former Ernst & Young Partner Hee H. Lee to Board, Strengthening Governance (2026-04-17)
• Alps Group Publishes Positive Clinical Safety Data for Autologous NK Cell Therapy (2026-02-23)

Insider Transactions

ALPS files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.